# Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices

> **NCT07268937** · — · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 25 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)

## Interventions

- **DEVICE:** CAP (Controlled Attenuation Parameter) module implemented on the Fibroscan machine.

## Key facts

- **NCT ID:** NCT07268937
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07268937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07268937, "Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07268937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*